Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988111876066
Publisher
SAGE Publications
Online
2018-03-29
DOI
10.1177/0269881118760662
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
- (2017) Jasmina Mallet et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Psychological symptomatology and impaired prepulse inhibition of the startle reflex are associated with cannabis-induced psychosis
- (2017) Isabel Morales-Muñoz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabis-associated psychosis: Neural substrate and clinical impact
- (2017) R.M. Murray et al. NEUROPHARMACOLOGY
- Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review
- (2017) Ana Adan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis
- (2017) Tabea Schoeler et al. PSYCHIATRY RESEARCH
- Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study
- (2017) Nehal P. Vadhan et al. PSYCHIATRY RESEARCH
- The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition
- (2017) Siri Helle et al. PSYCHIATRY RESEARCH
- Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis
- (2017) E. Foglia et al. PSYCHOLOGICAL MEDICINE
- Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex
- (2017) Silvia Rigucci et al. PSYCHOPHARMACOLOGY
- Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
- (2017) Sagnik Bhattacharyya et al. Scientific Reports
- Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use
- (2017) Ahmed Mhalla et al. Annals of General Psychiatry
- Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study
- (2017) Marise W.J. Machielsen et al. SCHIZOPHRENIA RESEARCH
- Mismatch negativity: A simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia
- (2017) Michael Avissar et al. SCHIZOPHRENIA RESEARCH
- Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets
- (2017) Daniela Vergara et al. Scientific Reports
- Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
- (2016) Mohini Ranganathan et al. BIOLOGICAL PSYCHIATRY
- Human Laboratory Studies on Cannabinoids and Psychosis
- (2016) Mohamed Sherif et al. BIOLOGICAL PSYCHIATRY
- Association Between Cannabis and Psychosis: Epidemiologic Evidence
- (2016) Suzanne H. Gage et al. BIOLOGICAL PSYCHIATRY
- An Introduction to the Endogenous Cannabinoid System
- (2016) Hui-Chen Lu et al. BIOLOGICAL PSYCHIATRY
- Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of1H-MRS studies
- (2016) Remmelt R. Schür et al. HUMAN BRAIN MAPPING
- Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis
- (2016) Anahita Bassir Nia et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Deficits in striatal dopamine release in cannabis dependence
- (2016) E van de Giessen et al. MOLECULAR PSYCHIATRY
- Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males
- (2016) Corinde E Wiers et al. NEUROPSYCHOPHARMACOLOGY
- Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
- (2016) Marco Colizzi et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis
- (2016) Lisa Buchy et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis
- (2016) M. J. McHugh et al. PSYCHOLOGICAL MEDICINE
- Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
- (2016) Arianna Marconi et al. SCHIZOPHRENIA BULLETIN
- Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
- (2016) Rashmi Patel et al. BMJ Open
- Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History
- (2016) Ana González-Pinto et al. PLoS One
- Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
- (2015) A. M. Auther et al. ACTA PSYCHIATRICA SCANDINAVICA
- Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use
- (2015) Hannah Myles et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
- (2015) Lisa Buchy et al. BMC Psychiatry
- Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia
- (2015) Johannes Rentzsch et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Cognitive correlates of frontoparietal network connectivity ‘at rest’ in individuals with differential risk for psychotic disorder
- (2015) S.C.T. Peeters et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date
- (2015) Musa Basser Sami et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis
- (2015) Sagnik Bhattacharyya et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects
- (2015) Matthew J. Smith et al. HIPPOCAMPUS
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
- (2015) Ryan Vandrey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cannabis Abuse Effects on Prepulse Inhibition in Patients With First Episode Psychosis in Schizophrenia
- (2015) Isabel Morales-Muñoz et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders
- (2015) Laura Koenders et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review
- (2015) Robin P Wilson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
- (2015) Adam Winstock et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabis: debated schizophrenia link
- (2015) Matthew Large et al. NATURE
- Perspective: Be clear about the real risks
- (2015) Matthew Hill NATURE
- Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed
- (2015) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC
- (2015) Rajiv Radhakrishnan et al. NEUROPSYCHOPHARMACOLOGY
- Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
- (2015) E. Appiah-Kusi et al. PSYCHOLOGICAL MEDICINE
- Effect of high-potency cannabis on corpus callosum microstructure
- (2015) S. Rigucci et al. PSYCHOLOGICAL MEDICINE
- Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
- (2015) Matthijs G. Bossong et al. PSYCHOPHARMACOLOGY
- Application of cross-species PET imaging to assess neurotransmitter release in brain
- (2015) Sjoerd J. Finnema et al. PSYCHOPHARMACOLOGY
- Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study
- (2015) Jennifer L. Seddon et al. SCHIZOPHRENIA BULLETIN
- Sensorimotor gating, cannabis use and the risk of psychosis
- (2015) T. Winton-Brown et al. SCHIZOPHRENIA RESEARCH
- Altered cortical maturation in adolescent cannabis users with and without schizophrenia
- (2015) Katherine A. Epstein et al. SCHIZOPHRENIA RESEARCH
- Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis
- (2015) Chelsea Arnold et al. SCHIZOPHRENIA RESEARCH
- Associations of Cannabis and Cigarette Use with Depression and Anxiety at Age 18: Findings from the Avon Longitudinal Study of Parents and Children
- (2015) Suzanne H. Gage et al. PLoS One
- Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis
- (2014) Ruud van Winkel et al. Annual Review of Clinical Psychology
- Do reward-processing deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of physiological response to natural rewards and drug cues
- (2014) Clifford Cassidy et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study
- (2014) Marise WJ Machielsen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Genetic predisposition to schizophrenia associated with increased use of cannabis
- (2014) R A Power et al. MOLECULAR PSYCHIATRY
- Early phytocannabinoid chemistry to endocannabinoids and beyond
- (2014) Raphael Mechoulam et al. NATURE REVIEWS NEUROSCIENCE
- Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use
- (2014) Romina Mizrahi et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
- (2014) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Characterizing cannabis-induced psychosis: A study with prepulse inhibition of the startle reflex
- (2014) Isabel Morales-Muñoz et al. PSYCHIATRY RESEARCH
- Prognosis of schizophrenia in persons with and without a history of cannabis use
- (2014) E. Manrique-Garcia et al. PSYCHOLOGICAL MEDICINE
- Cannabis use and transition to psychosis in people at ultra-high risk
- (2014) L. R. Valmaggia et al. PSYCHOLOGICAL MEDICINE
- Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia
- (2014) David W. Volk et al. SCHIZOPHRENIA RESEARCH
- Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences
- (2014) W.A. van Gastel et al. SCHIZOPHRENIA RESEARCH
- Early somatosensory processing in individuals at risk for developing psychoses
- (2014) Florence Hagenmuller et al. Frontiers in Behavioral Neuroscience
- Gone to Pot – A Review of the Association between Cannabis and Psychosis
- (2014) Rajiv Radhakrishnan et al. Frontiers in Psychiatry
- Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
- (2013) Michael A.P. Bloomfield et al. BIOLOGICAL PSYCHIATRY
- Combined Grey Matter VBM and White Matter TBSS Analysis in Young First Episode Psychosis Patients With and Without Cannabis Consumption
- (2013) Sven Haller et al. BRAIN TOPOGRAPHY
- Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia
- (2013) Berend Malchow et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls
- (2013) Mirjam J. van Tricht et al. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
- Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
- (2013) E M P Poels et al. MOLECULAR PSYCHIATRY
- Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
- (2013) Jenny Ceccarini et al. NEUROIMAGE
- Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study
- (2013) Rebecca Kuepper et al. PLoS One
- Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study
- (2013) Josiane Bourque et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Cannabis use and brain structural alterations of the cingulate cortex in early psychosis
- (2013) Charlotte Rapp et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users
- (2013) M. Di Forti et al. SCHIZOPHRENIA BULLETIN
- Cannabis-Related Working Memory Deficits and Associated Subcortical Morphological Differences in Healthy Individuals and Schizophrenia Subjects
- (2013) M. J. Smith et al. SCHIZOPHRENIA BULLETIN
- Cannabis use, cognition and brain structure in first-episode psychosis
- (2013) Paulo Jannuzzi Cunha et al. SCHIZOPHRENIA RESEARCH
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
- (2012) Sagnik Bhattacharyya ARCHIVES OF GENERAL PSYCHIATRY
- The Association between Cannabis Use and Earlier Age at Onset of Schizophrenia and other Psychoses: Meta-analysis of Possible Confounding Factors
- (2012) Nicholas Myles et al. CURRENT PHARMACEUTICAL DESIGN
- Neural Mechanisms for the Cannabinoid Modulation of Cognition and Affect in Man: A Critical Review of Neuroimaging Studies
- (2012) Sagnik Bhattacharyya et al. CURRENT PHARMACEUTICAL DESIGN
- Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function
- (2012) S Bhattacharyya et al. MOLECULAR PSYCHIATRY
- Endocannabinoid Signaling and Synaptic Function
- (2012) Pablo E. Castillo et al. NEURON
- Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
- (2012) Romina Mizrahi et al. NEUROPSYCHOPHARMACOLOGY
- Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems
- (2012) Nathalie Ginovart et al. NEUROPSYCHOPHARMACOLOGY
- Incidence of Schizophrenia and Other Psychoses in England, 1950–2009: A Systematic Review and Meta-Analyses
- (2012) James B. Kirkbride et al. PLoS One
- Persistent cannabis users show neuropsychological decline from childhood to midlife
- (2012) M. H. Meier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse
- (2012) O. E. Onwuameze et al. PSYCHOLOGICAL MEDICINE
- Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia
- (2012) K. A. Welch et al. PSYCHOLOGICAL MEDICINE
- Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome
- (2012) A. M. Auther et al. PSYCHOLOGICAL MEDICINE
- Delayed preattentional functioning in early psychosis patients with cannabis use
- (2012) Nicole Pesa et al. PSYCHOPHARMACOLOGY
- Increased gray matter density in patients with schizophrenia and cannabis use: A voxel-based morphometric study using DARTEL
- (2012) Thomas Schnell et al. SCHIZOPHRENIA RESEARCH
- Alteration to hippocampal shape in cannabis users with and without schizophrenia
- (2012) Nadia Solowij et al. SCHIZOPHRENIA RESEARCH
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
- (2012) Else-Marie Løberg et al. Frontiers in Psychiatry
- Cannabis Use and Earlier Onset of Psychosis
- (2011) Matthew Large et al. ARCHIVES OF GENERAL PSYCHIATRY
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- (2011) Ethan B Russo BRITISH JOURNAL OF PHARMACOLOGY
- Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia
- (2011) Killian A. Welch et al. BRITISH JOURNAL OF PSYCHIATRY
- Substance use and regional gray matter volume in individuals at high risk of psychosis
- (2011) James M. Stone et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults
- (2011) Martin Cohen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex
- (2011) C. J. Stagg et al. JOURNAL OF PHYSIOLOGY-LONDON
- History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability
- (2011) Paul RA Stokes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Parietal Lobe Volume Deficits in Adolescents With Schizophrenia and Adolescents With Cannabis Use Disorders
- (2011) Sanjiv Kumra et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study
- (2011) Toby T Winton-Brown et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings
- (2011) J. H. Meijer et al. PSYCHOLOGICAL MEDICINE
- Cerebellar white-matter changes in cannabis users with and without schizophrenia
- (2011) N. Solowij et al. PSYCHOLOGICAL MEDICINE
- The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis
- (2011) Rachel A. Rabin et al. SCHIZOPHRENIA RESEARCH
- Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: An in vivo SPECT study
- (2011) Gemma Safont et al. SCHIZOPHRENIA RESEARCH
- Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS)
- (2011) A. James et al. SCHIZOPHRENIA RESEARCH
- Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects
- (2011) Johannes Rentzsch et al. SCHIZOPHRENIA RESEARCH
- Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
- (2011) Beng-Choon Ho et al. SCHIZOPHRENIA RESEARCH
- Supply and demand for endocannabinoids
- (2011) Bradley E. Alger et al. TRENDS IN NEUROSCIENCES
- Association Between Cannabis Use and Psychosis-Related Outcomes Using Sibling Pair Analysis in a Cohort of Young Adults
- (2010) John McGrath et al. ARCHIVES OF GENERAL PSYCHIATRY
- Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia
- (2010) Petra Habets et al. BIOLOGICAL PSYCHIATRY
- Psychosis reactivity to cannabis use in daily life: an experience sampling study
- (2010) Cécile Henquet et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia
- (2010) Monica Rais et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
- (2010) Emma Barkus et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge
- (2010) Paul R.A. Stokes et al. NEUROIMAGE
- Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
- (2010) Stephen M Eggan et al. NEUROPSYCHOPHARMACOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
- (2010) M. Yucel et al. SCHIZOPHRENIA BULLETIN
- The Impact of Substance Use on Brain Structure in People at High Risk of Developing Schizophrenia
- (2010) Killian A. Welch et al. SCHIZOPHRENIA BULLETIN
- Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
- (2009) Sagnik Bhattacharyya et al. ARCHIVES OF GENERAL PSYCHIATRY
- Comorbid substance abuse and brain morphology in recent-onset psychosis
- (2009) Thomas Wobrock et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia
- (2009) Nienke Dekker et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse
- (2009) Thomas Wobrock et al. PSYCHOPHARMACOLOGY
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
- (2009) O. D. Howes et al. SCHIZOPHRENIA BULLETIN
- Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005
- (2009) Martin Frisher et al. SCHIZOPHRENIA RESEARCH
- Excessive Brain Volume Loss Over Time in Cannabis-Using First-Episode Schizophrenia Patients
- (2008) Monica Rais et al. AMERICAN JOURNAL OF PSYCHIATRY
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
- (2008) Stefan J. Borgwardt et al. BIOLOGICAL PSYCHIATRY
- Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology
- (2008) David J. Potter et al. JOURNAL OF FORENSIC SCIENCES
- Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
- (2008) Matthijs G Bossong et al. NEUROPSYCHOPHARMACOLOGY
- Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis
- (2008) C CORCORAN et al. SCHIZOPHRENIA RESEARCH
- Cannabis use and brain structural alterations in first episode schizophrenia — A region of interest, voxel based morphometric study
- (2008) Srihari S. Bangalore et al. SCHIZOPHRENIA RESEARCH
- Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use
- (2008) Miguel Ruiz-Veguilla et al. SCHIZOPHRENIA RESEARCH
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now